1982
DOI: 10.1111/j.1365-2133.1982.tb00904.x
|View full text |Cite
|
Sign up to set email alerts
|

Severe oral lichen planus: treatment with an aromatic retinoid (etretinate)

Abstract: A double-blind study of twenty-eight patients with severe oral lichen planus treated with etretinate (75 mg daily) or a placebo for 2 months, showed that the oral retinoid had a marked beneficial effect. Nine non-responders who had received only placebo then entered an open cross-over study and they responded well to etretinate. Etretinate thus provided effective symptomatic relief for severe oral lichen planus, but side-effects were common, and six patients stopped treatment because of them.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
49
0
2

Year Published

1986
1986
2015
2015

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 96 publications
(51 citation statements)
references
References 9 publications
0
49
0
2
Order By: Relevance
“…Indeed, topical steroids or retinoic acid are usually inefficient. Beneficial effects of dapsone and griseofulvin have been only occasionally reported [1,2], Systemic steroids or retinoids are reported by most authors to give satisfying results [3]; however, high doses are often necessary for several months lead ing to poorly tolerated side effects [4], For this reason, we have attempted to treat four patients with locally applied ciclosporin A (CsA) in an open trial.…”
mentioning
confidence: 99%
“…Indeed, topical steroids or retinoic acid are usually inefficient. Beneficial effects of dapsone and griseofulvin have been only occasionally reported [1,2], Systemic steroids or retinoids are reported by most authors to give satisfying results [3]; however, high doses are often necessary for several months lead ing to poorly tolerated side effects [4], For this reason, we have attempted to treat four patients with locally applied ciclosporin A (CsA) in an open trial.…”
mentioning
confidence: 99%
“…Thus, systemic therapies, such as oral retinoids and cyclosporine, are scarce, of questionable efficacy, and with significant adverse events [14,15,16,17,18]. As for the local therapies available, there is not strong evidence for the effectiveness of any single treatment, including topical corticosteroids, which are currently the first-line accepted therapy for OELP [1].…”
Section: Discussionmentioning
confidence: 99%
“…Dosis más elevadas de etretinato, 75 mg/día, durante dos meses, proporcionan una mejoría clínica de las lesiones (47), pero a largo plazo (un año), los pacientes están en la misma situación que antes de iniciar el tratamiento (48). Con estas dosis además se padecen muchos efectos adversos e incluso algunos pacientes, tienen que suspender el tratamiento (47).…”
Section: Retinoides Sistémicosunclassified